Interleukin-23 (IL-23) is a key driver of chronic inflammatory diseases, yet current therapies rely on costly monoclonal antibodies. This study aims to identify small-molecule IL-23 inhibitors using an in silico approach that mimics antibody interactions. The structure of IL-23 and the monoclonal antibody Risankizumab was reconstructed using homology modeling and deep learning. Key binding sites were characterized and used to generate 3D pharmacophore models, which guided virtual screening of compounds from DrugBank and ZINC12 databases. Top candidates were evaluated via ADMET filtering, molecular docking, molecular dynamics simulations and MM/GBSA binding free energy calculations. ZINC20572287 (r3-7) demonstrated stable binding within the IL-23p19 pocket and maintained strong hydrogen bonding over a 600 ns simulation. In contrast, no potent IL-12p40 inhibitors were identified. These findings suggest r3-7 as a promising scaffold for developing cost-effective IL-23-targeted therapeutics. Graphical Abstract
Thai, Khac-Minh, Vu, Thi-Thanh-Thao, Mai, Quang-Minh et al. Structure-based screening of small-molecule interleukin-23 inhibitors inspired by monoclonal antibody interactions. // Molecular Diversity. – 2026. – DOI: 10.1007/s11030-025-11257-9. – URL: http://link.springer.com/openurl/fulltext?id=doi:10.1007/s11030-025-11257-9
Thai, Khac-Minh, Vu, Thi-Thanh-Thao, Mai, Quang-Minh, Le, & Minh-Tri (2026). Structure-based screening of small-molecule interleukin-23 inhibitors inspired by monoclonal antibody interactions. Molecular Diversity. https://doi.org/10.1007/s11030-025-11257-9
Thai, et al. “Structure-based screening of small-molecule interleukin-23 inhibitors inspired by monoclonal antibody interactions.” Molecular Diversity, 2026. doi:10.1007/s11030-025-11257-9.
@article{Thai2026,
title = {Structure-based screening of small-molecule interleukin-23 inhibitors inspired by monoclonal antibody interactions},
author = {Thai and Khac-Minh and Vu and Thi-Thanh-Thao and Mai and Quang-Minh and Le and Minh-Tri},
journal = {Molecular Diversity},
year = {2026},
doi = {10.1007/s11030-025-11257-9},
url = {http://link.springer.com/openurl/fulltext?id=doi:10.1007/s11030-025-11257-9}
}
Large extracellular vesicles (lEVs) are heterogeneous structures with sizes that exceed 200 nm. Unlike small extracellular vesicles, which originate from either the endosomal system or the plasma membrane, most lEVs stem directly from...
Chaperone-mediated autophagy (CMA), the first-described selective lysosomal degradation pathway, is distinguished from other degradative pathways by the unique mechanism by which substrates reach the lysosomal lumen: CMA relies on a...
This Review focuses on the choice between homologous recombination and non-homologous end joining in DNA double-strand break repair. The antagonistic roles of 53BP1 and BRCA1–BARD1, the contribution of RNA–DNA hybrids and implications...
A 2010 paper identified PRDM9 as the sequence-specific regulator of meiotic recombination hotspots, showing it co-evolves with its rapidly changing binding motifs.
Genome editing is maturing from a one-size-fits-all system into a highly specialized ecosystem that includes a dizzying array of tools. In this Comment, we discuss the current and future use of Cas-induced homology-directed repair for...